Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Asian markets drive Q1 revenue growth at Carlsberg

(Sharecast News) - Danish brewing giant Carlsberg on Tuesday announced a DKK1.0bn (£110m) share buyback after a solid start to 2024 with strong growth in Asia and Central and Eastern Europe. Revenues were up 6.4% on an organic basis, with growth in Asia at 7.6% - helped by strong performances in China and Vietnam - following by a 7.3% increase in Central & Eastern Europe and India (CEEI) and 5.1% growth in Western Europe.

Volumes grew at a slower pace - rising 2.1% on a group level to 29.2m hectoliters - but price increases meant headline revenue growth was 4%.

Volume growth was driven by its premium beer brands such as Carlsberg and Tuborg growing 8%, while alcohol-free brew volumes rose 2% and drinks in the 'Beyond Beer' category fell 1%.

Volumes rose 3.1% in Asia in the first quarter, with China in particular seeing growth of 5% helped by a Chinese New Year boost; volumes rose 2.2% in CEEI and 0.2% in Western Europe.

"We've had a solid start to the year with volume and revenue growth in all three regions. We're particularly satisfied with the growth of our premium portfolio and the volume and revenue growth in Asia, both of which are important strategic growth drivers for the group," said chief executive Jacob Aarup-Andersen.

"First-quarter performance was in line with expectations, and we maintain our full-year earnings outlook," he said.

Carlsberg said it continues to expect to grow organic operating profits by 1% to 5% in 2024, though currency movemments will have around a DKK250m negative impact on reported operating profits.

The stock was down 0.8% at kr945.20 by 1051 in Copenhagen.

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.